Woo Sik Yu1, Hyo Chae Paik2, Seok Jin Haam3, Chang Young Lee2, Kyung Sik Nam2, Hee Suk Jung2, Young Woo Do2, Jee Won Shu2, Jin Gu Lee2. 1. Department of Thoracic Surgery, Armed Forces Capital Hospital, Seongnam-si, Gyeonggi-do, Korea;; Department of Medicine, The Graduate School of Yonsei University, Seoul, Korea; 2. Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yonsei University, Seoul, Korea ; 3. Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Suwon, Korea.
Abstract
BACKGROUND: The study objective was to compare the outcomes of intraoperative routine use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) versus selective use of cardiopulmonary bypass (CPB). METHODS: Between January 2010 and February 2013, 41 lung transplantations (LTx) were performed, and CPB was used as a primary cardiopulmonary support modality by selective basis (group A). Between March 2013 and December 2014, 41 LTx were performed, and ECMO was used routinely (group B). The two groups were compared retrospectively. RESULTS: The operative time was significantly longer in group A (group A, 458 min; group B, 420 min; P=0.041). Postoperatively, patients in group B had less fresh frozen plasma (FFP) transfusion (P=0.030). Complications were not different between the two groups. The 30- and 90-day survival rates were better in group B (30-day survival: group A, 75.6%; group B, 95.1%, P=0.012; 90-day survival: group A, 68.3%; group B, 87.8%, P=0.033). The 1-year survival showed better trends in group B, but it was not significant. Forced vital capacity (FVC) at 1, 3, and 6 months after LTx was better in group B than in group A (1 month: group A, 43.8%; group B, 52.9%, P=0.043; 3 months: group A, 45.5%; group B, 59.0%, P=0.005; 6 months: group A, 51.5%; group B, 65.2%, P=0.020). Forced expiratory volume in 1 second (FEV1) at 3 months after LTx was better in patients in group B than that in patient in group A (group A, 53.3%; group B, 67.5%, P=0.017). CONCLUSIONS: Routine use of ECMO during LTx could improve early outcome and postoperative lung function without increased extracorporeal-related complication such as vascular and neurologic complications.
BACKGROUND: The study objective was to compare the outcomes of intraoperative routine use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) versus selective use of cardiopulmonary bypass (CPB). METHODS: Between January 2010 and February 2013, 41 lung transplantations (LTx) were performed, and CPB was used as a primary cardiopulmonary support modality by selective basis (group A). Between March 2013 and December 2014, 41 LTx were performed, and ECMO was used routinely (group B). The two groups were compared retrospectively. RESULTS: The operative time was significantly longer in group A (group A, 458 min; group B, 420 min; P=0.041). Postoperatively, patients in group B had less fresh frozen plasma (FFP) transfusion (P=0.030). Complications were not different between the two groups. The 30- and 90-day survival rates were better in group B (30-day survival: group A, 75.6%; group B, 95.1%, P=0.012; 90-day survival: group A, 68.3%; group B, 87.8%, P=0.033). The 1-year survival showed better trends in group B, but it was not significant. Forced vital capacity (FVC) at 1, 3, and 6 months after LTx was better in group B than in group A (1 month: group A, 43.8%; group B, 52.9%, P=0.043; 3 months: group A, 45.5%; group B, 59.0%, P=0.005; 6 months: group A, 51.5%; group B, 65.2%, P=0.020). Forced expiratory volume in 1 second (FEV1) at 3 months after LTx was better in patients in group B than that in patient in group A (group A, 53.3%; group B, 67.5%, P=0.017). CONCLUSIONS: Routine use of ECMO during LTx could improve early outcome and postoperative lung function without increased extracorporeal-related complication such as vascular and neurologic complications.
Entities:
Keywords:
Lung transplantation (LTx); extracorporeal life support (ECLS); venoarterial (VA)
Authors: Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Joseph W Rossano; Josef Stehlik Journal: J Heart Lung Transplant Date: 2015-09-03 Impact factor: 10.247
Authors: Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper Journal: Eur Respir J Date: 2015-08-29 Impact factor: 16.671
Authors: Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill Journal: J Heart Lung Transplant Date: 2005-06-04 Impact factor: 10.247
Authors: Tiago N Machuca; Stephane Collaud; Olaf Mercier; Maureen Cheung; Valerie Cunningham; S Joseph Kim; Sassan Azad; Lianne Singer; Kazuhiro Yasufuku; Marc de Perrot; Andrew Pierre; Karen McRae; Thomas K Waddell; Shaf Keshavjee; Marcelo Cypel Journal: J Thorac Cardiovasc Surg Date: 2014-11-21 Impact factor: 5.209
Authors: Hartmuth B Bittner; Christian Binner; Sven Lehmann; Thomas Kuntze; Ardawan Rastan; Friedrich W Mohr Journal: Eur J Cardiothorac Surg Date: 2006-12-26 Impact factor: 4.191
Authors: Christian A Bermudez; Akira Shiose; Stephen A Esper; Norihisa Shigemura; Jonathan D'Cunha; Jay K Bhama; Thomas J Richards; Peter Arlia; Maria M Crespo; Joseph M Pilewski Journal: Ann Thorac Surg Date: 2014-10-22 Impact factor: 4.330
Authors: Neil R MacIntyre; Scott K Epstein; Shannon Carson; David Scheinhorn; Kent Christopher; Sean Muldoon Journal: Chest Date: 2005-12 Impact factor: 9.410
Authors: Fabio Ius; Wiebke Sommer; Igor Tudorache; Murat Avsar; Thierry Siemeni; Jawad Salman; Ulrich Molitoris; Clemens Gras; Bjoern Juettner; Jakob Puntigam; Joerg Optenhoefel; Mark Greer; Nicolaus Schwerk; Jens Gottlieb; Tobias Welte; Marius M Hoeper; Axel Haverich; Christian Kuehn; Gregor Warnecke Journal: J Heart Lung Transplant Date: 2015-09-05 Impact factor: 10.247
Authors: Woo Sik Yu; Jee Won Suh; Seung Hwan Song; Hyo Chae Paik; Song Yee Kim; Moo Suk Park; Jin Gu Lee Journal: PLoS One Date: 2019-04-03 Impact factor: 3.240